WILEY MATTHEW T. (Chief Commercial Officer) received a stock award from DEFINIUM THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/5/2026ACC: 0001193125-26-039598
Officer· Chief Commercial Officer
Since Feb 2026
+115K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
115K acquired
Non-Derivative Transactions1
Common Shares
Direct
Shares
+115K
Price / share
—
Trade value
—
% of position
New position
2/3/2026
0.00→115K
Total
Net shares
+115K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 2/3/2026 | A · Award | +115K | — | — | New position | 0.00 | 115K |
| Total | +115K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported